carvedilol has been researched along with Colitis Gravis in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pretreatment with carvedilol attenuated LPO elevation, mucus content and sulfhydryl group inhibitions." | 1.42 | Carvedilol attenuates inflammatory biomarkers and oxidative stress in a rat model of ulcerative colitis. ( Abuohashish, HM; Ahmed, MM; Al-Hosaini, KA; Al-Rejaie, SS; Fatani, AJ; Parmar, MY, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fatani, AJ | 1 |
| Al-Hosaini, KA | 1 |
| Ahmed, MM | 1 |
| Abuohashish, HM | 1 |
| Parmar, MY | 1 |
| Al-Rejaie, SS | 1 |
1 other study available for carvedilol and Colitis Gravis
| Article | Year |
|---|---|
Carvedilol attenuates inflammatory biomarkers and oxidative stress in a rat model of ulcerative colitis.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Carbazoles; Carvedilol; Colitis, Ulcera | 2015 |